Partial Lipodystrophy
📧 Sign up to get email alerts when something new happens for Partial Lipodystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance [Phase 2]
A Phase 2 trial is evaluating pegvisomant, a growth hormone receptor antagonist, for severe insulin resistance due to insulin receptor mutat…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: MEASuRE: Metreleptin Effectiveness And Safety Registry
MEASuRE is a registry studying the effectiveness and safety of metreleptin for generalized lipodystrophy and partial lipodystrophy. The stud…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 [Phase 2]
The University of Michigan is conducting a Phase 2 trial to evaluate tirzepatide for partial lipodystrophy, and the study is currently recru…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL [Phase 3]
A Phase 3 trial evaluating daily subcutaneous metreleptin in partial lipodystrophy, sponsored by Amryt Pharma; the study is currently ACTIVE…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy [Phase 4]
An open-label Phase 4 study from Amryt Pharma is evaluating metreleptin in patients with partial lipodystrophy, and recruitment is ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Trial of Leptin Replacement Therapy in Patients With Lipodystrophy [Phase 2, Phase 3]
Phase 2/3 trial evaluating leptin replacement therapy in lipodystrophy patients has completed with results posted.